As ADC approvals grow and pipelines expand, dose selection has become one of the field’s biggest challenges, and Project Optimus has resulted in pushing developers to move beyond maximum tolerated dose and define regimens that truly balance safety and efficacy.

Time: 8:00 AM – 5:00 PM

Venue details: Revere Hotel Boston Common, 200 Stuart Street, Boston, Massachusetts, 02116, United States

Prices: USD 2599.00 – USD 5097.00

Speakers: Abhishek Sathe, Associate Director, Clinical Pharmacology, Gilead, and more